CLOV CLOVER HEALTH INV CORP

Counterpart Health Expands Leadership to Accelerate Enterprise Partnerships and Regional Adoption of AI-Powered Platform Counterpart Assistant

Counterpart Health Expands Leadership to Accelerate Enterprise Partnerships and Regional Adoption of AI-Powered Platform Counterpart Assistant

New VP Blaine Lindsey to Drive National Enterprise Growth; Gulf Region President Shannon Jacobs to Scale Operations in High-Need Markets

SAN FRANCISCO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI‑powered physician‑enablement platform, today announced that Blaine Lindsey, Vice President of Enterprise Growth and Partnerships and Shannon Jacobs, President of Market Operations for the Gulf Region have joined Counterpart Health. These two strategic leadership appointments are integral to nurturing new partnerships and ensuring operational support for successful adoption of Counterpart Assistant (CA).

These appointments come during a time when many physicians lack the technology infrastructure and operational support to successfully implement value-based care, especially in underserved areas where clinicians may have limited resources. CA addresses this gap by surfacing AI-powered insights into existing clinician workflows, enabling them to identify high-risk patients, manage chronic conditions earlier, and support value-based care at scale.

"Counterpart Assistant was built to serve the full spectrum of physician practices," said Conrad Wai, CEO of Counterpart Health. "Whether we're partnering with large health systems, national plans, regional payviders, or independent practices in rural communities, we’ve identified that the need is the same: actionable intelligence that improves care without overwhelming providers. Blaine and Shannon bring the expertise to scale our impact while ensuring we deliver meaningful results.”

Driving National Enterprise Partnerships

As Vice President of Enterprise Growth and Partnerships, Blaine Lindsey will be instrumental in bringing Counterpart Assistant to more risk-bearing organizations, and ultimately, more clinicians and patients. Lindsey is a highly accomplished healthcare leader and nationally recognized value-based care expert whose experience includes leading national provider and enterprise partnerships at Aledade and Honest Health as well as driving expansion as Chief Growth Officer at AnsibleHealth. Lindsey brings a proven track record of building innovative, high performance partnerships that deliver both clinical and financial value.

“Counterpart’s technology has proven itself in real-world deployments and consistently outperforms in actual practice settings,” said Blaine Lindsey. “The healthcare ecosystem is taking notice of Counterpart Assistant with new partners requesting access, and inbound demand is building quickly. My priority is to convert that momentum into strategic partnerships that deliver reliable, measurable results for clinicians while scaling adoption within existing workflows.”

Scaling Operations in the Gulf Region's Diverse Markets

Shannon Jacobs joins as President of Market Operations for the Gulf Region, where he'll lead the expansion and performance optimization of Counterpart’s growing physician network. Jacobs most recently served as President of the Gulf Region at Main Street Health, the nation's largest value-based care provider in rural communities. He brings deep operational expertise in launching new markets, building high-performing teams, and supporting excellent clinical care delivery across diverse practice environments.



"I've worked closely with primary care providers for years and have tremendous respect for how they navigate a myriad of challenges, especially in areas where resources are tight and patient complexity is high,” said Shannon Jacobs. “What excites me about Counterpart Assistant is the opportunity to support these hard-working providers with valuable clinical data and AI-enabled technology that fits into their existing workflows and allows them to deliver high quality care to their patients.”

About Counterpart Health

, a subsidiary of Clover Health Investments, Corp., or Clover Health, is a leading AI-powered physician enablement platform transforming care delivery. Born out of Clover Health as Clover Assistant, Counterpart Health’s flagship software platform, Counterpart Assistant, provides clinically intuitive insights that help clinicians better manage chronic conditions and deliver high-quality care. Counterpart Health extends this powerful data-driven technology platform beyond Clover Health’s Medicare Advantage plan, bringing its benefits to a wider audience to improve patient outcomes and reduce healthcare costs nationwide. Several published studies demonstrate the technology’s impact on , , , and management, and .

Investor Relations:

Ryan Schmidt

Press Inquiries:



EN
06/10/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CLOVER HEALTH INV CORP

 PRESS RELEASE

Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provide...

Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance Business Highlights: Generated full year 2025 Adjusted EBITDA profitability while growing membership by 38% and Insurance revenue by 41% year-over-yearAchieved industry-leading 2026 AEP growth of 53% year-over-year with strong returning member retentionExpect improving cohort economics powered by Clover Assistant to drive our first-ever full year of GAAP Net Income profitability in 2026 Financial Results: Full year 2025 Medicare Advantage membership of 113,803, up 38% year-over-yearFull ...

 PRESS RELEASE

Clover Health to Participate in Upcoming Leerink 2026 Global Healthcar...

Clover Health to Participate in Upcoming Leerink 2026 Global Healthcare Conference WILMINGTON, Del., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the Leerink 2026 Global Healthcare Conference on Tuesday, March 10, 2026, at 9:20 a.m. Eastern Time. A live webcast and replay of the presentation and Q&A session will be accessible on Clover Health's investor relations website at . About Clover Health:Clover Health (Nasdaq: CLOV) i...

 PRESS RELEASE

Clover Health to Report Fourth Quarter and Full Year 2025 Financial Re...

Clover Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 WILMINGTON, Del., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the market closes on Thursday, February 26, 2026. The Company’s management will host a webcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the company’s business and financial performance for the quarter. Fourth Quarter and Full Year 2025 Conference Webcast Detail...

 PRESS RELEASE

Clover Health Announces 53% Growth in Medicare Advantage Membership Du...

Clover Health Announces 53% Growth in Medicare Advantage Membership During AEP, Increasing to 153,000 Members as of January 1, 2026; Expects First-Ever Full Year GAAP Net Income Profitability in 2026 Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income profitability in 2026.Disciplined, core-market growth, strong returning member retention, and improving cohort economics position Clover for compounding earnings and margin expansion.Powered by AI, Clover continues to bring industry-leading clinical quality to...

 PRESS RELEASE

Counterpart Health 2025 Results: How Better Clinical Decisions at Scal...

Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost Counterpart continues to demonstrate that unified data and real-time insights, delivered directly into the clinician’s workflow, drive measurable clinical and financial outcomes SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- , Inc. (“Counterpart” or the “Company”), a leading AI-powered physician-enablement platform and subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV), today released key 2025 highlights. The past year was defined by continued publication of research ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch